Bioterrorism constitutes a counter arena that may amplify or substitute for the natural control mechanisms signified by infectious diseases. Pharmaceutical biotechnology in itself represents a potential key resource for bioterrorism. This article focuses on microbiological, epidemiological, medical, technological, demographical, political, and strategic aspects of bioterrorism.